Market Research Logo

Global Vaccines Market Size By Age Group (Pediatric, Adult), By Technology (Conjugate, Attenuated, Inactivated, Recombinant, Toxoid), By Disease (Cancer, Hepatitis, Pneumococcal Disease, DTP, Dengue, Influenza, Human Papilloma Virus, Meningococcal Disease

Global Vaccines Market Size By Age Group (Pediatric, Adult), By Technology (Conjugate, Attenuated, Inactivated, Recombinant, Toxoid), By Disease (Cancer, Hepatitis, Pneumococcal Disease, DTP, Dengue, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus), Regional Outlook (U.S., Canada, Germany, UK, Spain, Russia, Italy, France, China, Japan, India, South Korea, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE, Qatar, Egypt), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 - 2025

Vaccines Market will exceed over USD 70 billion by 2025; as per a new research report.

Increasing demand for preventive vaccines, rising number of people suffering from infectious as well as non-infectious diseases globally will drive vaccines market over the forecast timeframe. Increasing government funding for vaccine development will further boost industry growth.

Widespread routine vaccination programmes, numerous initiatives undertaken by government to encourage vaccine administration especially in developing and underdeveloped countries will positively impact industry growth. Growing awareness about reduced mortality due to immunization should propel vaccines industry growth over the forecast period.

High adoption of new vaccines coupled with technological advancements should stimulate business growth. Moreover, strong product pipeline of leading companies such as Merck, Novavax, Emergent BioSolutions will lead to industry expansion over the coming years. However, high cost associated with transportation and storage of vaccines will limit vaccines market growth to certain extent over the foreseeable future.

Adult segment will witness 9.8% CAGR during the forecast period. Growing demand for cost-effective vaccines with simple delivery systems should drive segment growth. Rising awareness regarding reduced mortality rate due to immunization has stimulated adoption rate of vaccines in adult age-group.

Recombinant vaccine technology segment will grow lucratively over the forecast timeframe to account for more than 20% market share in 2025. Recombinant vaccines are more effective and advanced than conventional set of vaccines particularly in preventing occurrence of diseases such as typhoid, malaria and human papillomavirus (HPV) should drive segment growth.

Human papillomavirus disease segment will witness 8.4% CAGR during the forecast period. Increasing R&D by researchers to increase cross-protections against numerous types of HPV, to improve the half-life and reduce the number of vaccinations should drive segment growth. Company such as Inovio Pharmaceuticals is currently working on developing VGX-3100 vaccine to treat cervical dysplasia caused due to human papillomavirus.

U.S. vaccines market is anticipated to experience growth of 8.9% CAGR during the forecast timeframe. High adoption rate of vaccines to reduce incidence of infectious diseases along with several initiatives undertaken by government by increasing immunization rate and recommendations should stimulate business growth.

Japan vaccines market will grow significantly over the coming years to reach over USD 6.0 billion by 2025. Introduction of routine vaccination programme in October 2016 leading to introduction of numerous important and routine vaccines having higher rate of administration as compared to voluntary vaccines should drive Japan vaccines market.

Some of the major market players involved in global vaccines market are Merck, AstraZeneca, Johnson & Johnson, Novartis, Bristol-Myers Squibb, Abbott, Sanofi Pasteur, GlaxoSmithKline, Pfizer, Emergent BioSolutions, CSL, Astellas Pharma and Novavax. Firms are focusing on product launch to fortify their product base and market reach over the coming years.


Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Global vaccines industry 360 degree synopsis, 2014 - 2025
2.1.1. Business trends
2.1.2. Age group trends
2.1.3. Disease trends
2.1.4. Technology trends
2.1.5. Regional trends
Chapter 3. Vaccines Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2014 - 2025
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Increasing government funding for vaccine development
3.3.1.2. Increasing vaccines R&D in developed nations
3.3.1.3. Increasing disease prevalence in underdeveloped countries
3.3.1.4. Growing incidences of cancer & HIV in Asia Pacific
3.3.2. Industry pitfalls & challenges
3.3.2.1. High cost of vaccine storage and transportation
3.3.2.2. Stringent regulations for the approval of vaccines in developed nations
3.3.2.3. Drug-development hurdles
3.4. Growth potential analysis
3.4.1. By age group
3.4.2. By technology
3.4.3. By disease
3.5. Regulatory landscape
3.5.1. U.S
3.5.2. Europe
3.5.3. Asia Pacific
3.6. Reimbursement scenario
3.6.1. U.S
3.6.2. Europe
3.7. Technology landscape
3.8. Pricing analysis
3.9. Pipeline product analysis
3.9.1. Malaria
3.9.2. HIV
3.9.3. Zika
3.9.4. Ebola
3.10. Porter's analysis
3.11. Company market share analysis, 2017
3.11.1. Strategy dashboard
3.12. PESTEL analysis
Chapter 4. Vaccines Market, By Age group
4.1. Key segment trends
4.2. Pediatric
4.2.1. Market estimates and forecast, by region, 2014 - 2025
4.3. Adult
4.3.1. Market estimates and forecast, by region, 2014 - 2025
Chapter 5. Vaccines Market, By Technology
5.1. Key segment trends
5.2. Attenuated
5.2.1. Market estimates and forecast, by region, 2014 - 2025
5.3. Toxoid
5.3.1. Market estimates and forecast, by region, 2014 - 2025
5.4. Conjugate
5.4.1. Market estimates and forecast, by region, 2014 - 2025
5.5. Inactivated & subunit
5.5.1. Market estimates and forecast, by region, 2014 - 2025
5.6. Recombinant
5.6.1. Market estimates and forecast, by region, 2014 - 2025
5.7. Others
5.7.1. Market estimates and forecast, by region, 2014 - 2025
Chapter 6. Vaccines Market, By Disease
6.1. Key segment trends
6.2. Cancer
6.2.1. Market estimates and forecast, by region, 2014 - 2025
6.3. Hepatitis
6.3.1. Market estimates and forecast, by region, 2014 - 2025
6.4. Pneumococcal disease
6.4.1. Market estimates and forecast, by region, 2014 - 2025
6.5. DTP
6.5.1. Market estimates and forecast, by region, 2014 - 2025
6.6. Dengue
6.6.1. Market estimates and forecast, by region, 2014 - 2025
6.7. Influenza
6.7.1. Market estimates and forecast, by region, 2014 - 2025
6.8. Human papilloma virus
6.8.1. Market estimates and forecast, by region, 2014 - 2025
6.9. Meningococcal disease
6.9.1. Market estimates and forecast, by region, 2014 - 2025
6.10. Polio
6.10.1. Market estimates and forecast, by region, 2014 - 2025
6.11. Rotavirus
6.11.1. Market estimates and forecast, by region, 2014 - 2025
6.12. Others
6.12.1. Market estimates and forecast, by region, 2014 - 2025
Chapter 7. Vaccines Market, By Region
7.1. Key regional trends
7.2. North America
7.2.1. Market estimates and forecast, by country, 2014 - 2025
7.2.2. Market estimates and forecast, by age group, 2014 - 2025
7.2.3. Market estimates and forecast, by technology, 2014 - 2025
7.2.4. Market estimates and forecast, by disease, 2014 - 2025
7.2.5. U.S.
7.2.5.1. Market estimates and forecast, by age group, 2014 - 2025
7.2.5.2. Market estimates and forecast, by technology, 2014 - 2025
7.2.5.3. Market estimates and forecast, by disease, 2014 - 2025
7.2.6. Canada
7.2.6.1. Market estimates and forecast, by age group, 2014 - 2025
7.2.6.2. Market estimates and forecast, by technology, 2014 - 2025
7.2.6.3. Market estimates and forecast, by disease, 2014 - 2025
7.3. Europe
7.3.1. Market estimates and forecast, by country, 2014 - 2025
7.3.2. Market estimates and forecast, by age group, 2014 - 2025
7.3.3. Market estimates and forecast, by technology, 2014 - 2025
7.3.4. Market estimates and forecast, by disease, 2014 - 2025
7.3.5. Germany
7.3.5.1. Market estimates and forecast, by age group, 2014 - 2025
7.3.5.2. Market estimates and forecast, by technology, 2014 - 2025
7.3.5.3. Market estimates and forecast, by disease, 2014 - 2025
7.3.6. UK
7.3.6.1. Market estimates and forecast, by age group, 2014 - 2025
7.3.6.2. Market estimates and forecast, by technology, 2014 - 2025
7.3.6.3. Market estimates and forecast, by disease, 2014 - 2025
7.3.7. Italy
7.3.7.1. Market estimates and forecast, by age group, 2014 - 2025
7.3.7.2. Market estimates and forecast, by technology, 2014 - 2025
7.3.7.3. Market estimates and forecast, by disease, 2014 - 2025
7.3.8. France
7.3.8.1. Market estimates and forecast, by age group, 2014 - 2025
7.3.8.2. Market estimates and forecast, by technology, 2014 - 2025
7.3.8.3. Market estimates and forecast, by disease, 2014 - 2025
7.3.9. Spain
7.3.9.1. Market estimates and forecast, by age group, 2014 - 2025
7.3.9.2. Market estimates and forecast, by technology, 2014 - 2025
7.3.9.3. Market estimates and forecast, by disease, 2014 - 2025
7.3.10. Russia
7.3.10.1. Market estimates and forecast, by age group, 2014 - 2025
7.3.10.2. Market estimates and forecast, by technology, 2014 - 2025
7.3.10.3. Market estimates and forecast, by disease, 2014 - 2025
7.4. Asia Pacific
7.4.1. Market estimates and forecast, by country, 2014 - 2025
7.4.2. Market estimates and forecast, by age group, 2014 - 2025
7.4.3. Market estimates and forecast, by technology, 2014 - 2025
7.4.4. Market estimates and forecast, by disease, 2014 - 2025
7.4.5. China
7.4.5.1. Market estimates and forecast, by age group, 2014 - 2025
7.4.5.2. Market estimates and forecast, by technology, 2014 - 2025
7.4.5.3. Market estimates and forecast, by disease, 2014 - 2025
7.4.6. India
7.4.6.1. Market estimates and forecast, by age group, 2014 - 2025
7.4.6.2. Market estimates and forecast, by technology, 2014 - 2025
7.4.6.3. Market estimates and forecast, by disease, 2014 - 2025
7.4.7. Japan
7.4.7.1. Market estimates and forecast, by age group, 2014 - 2025
7.4.7.2. Market estimates and forecast, by technology, 2014 - 2025
7.4.7.3. Market estimates and forecast, by disease, 2014 - 2025
7.4.8. South Korea
7.4.8.1. Market estimates and forecast, by age group, 2014 - 2025
7.4.8.2. Market estimates and forecast, by technology, 2014 - 2025
7.4.8.3. Market estimates and forecast, by disease, 2014 - 2025
7.4.9. Australia
7.4.9.1. Market estimates and forecast, by age group, 2014 - 2025
7.4.9.2. Market estimates and forecast, by technology, 2014 - 2025
7.4.9.3. Market estimates and forecast, by disease, 2014 - 2025
7.5. Latin America
7.5.1. Market estimates and forecast, by country, 2014 - 2025
7.5.2. Market estimates and forecast, by age group, 2014 - 2025
7.5.3. Market estimates and forecast, by technology, 2014 - 2025
7.5.4. Market estimates and forecast, by disease, 2014 - 2025
7.5.5. Brazil
7.5.5.1. Market estimates and forecast, by age group, 2014 - 2025
7.5.5.2. Market estimates and forecast, by technology, 2014 - 2025
7.5.5.3. Market estimates and forecast, by disease, 2014 - 2025
7.5.6. Mexico
7.5.6.1. Market estimates and forecast, by age group, 2014 - 2025
7.5.6.2. Market estimates and forecast, by technology, 2014 - 2025
7.5.6.3. Market estimates and forecast, by disease, 2014 - 2025
7.5.7. Argentina
7.5.7.1. Market estimates and forecast, by age group, 2014 - 2025
7.5.7.2. Market estimates and forecast, by technology, 2014 - 2025
7.5.7.3. Market estimates and forecast, by disease, 2014 - 2025
7.6. Middle East & Africa
7.6.1. Market estimates and forecast, by country, 2014 - 2025
7.6.2. Market estimates and forecast, by age group, 2014 - 2025
7.6.3. Market estimates and forecast, by technology, 2014 - 2025
7.6.4. Market estimates and forecast, by disease, 2014 - 2025
7.6.5. South Africa
7.6.5.1. Market estimates and forecast, by age group, 2014 - 2025
7.6.5.2. Market estimates and forecast, by technology, 2014 - 2025
7.6.5.3. Market estimates and forecast, by disease, 2014 - 2025
7.6.6. Saudi Arabia
7.6.6.1. Market estimates and forecast, by age group, 2014 - 2025
7.6.6.2. Market estimates and forecast, by technology, 2014 - 2025
7.6.6.3. Market estimates and forecast, by disease, 2014 - 2025
7.6.7. UAE
7.6.7.1. Market estimates and forecast, by age group, 2014 - 2025
7.6.7.2. Market estimates and forecast, by technology, 2014 - 2025
7.6.7.3. Market estimates and forecast, by disease, 2014 - 2025
7.6.8. Qatar
7.6.8.1. Market estimates and forecast, by age group, 2014 - 2025
7.6.8.2. Market estimates and forecast, by technology, 2014 - 2025
7.6.8.3. Market estimates and forecast, by disease, 2014 - 2025
7.6.9. Egypt
7.6.9.1. Market estimates and forecast, by age group, 2014 - 2025
7.6.9.2. Market estimates and forecast, by technology, 2014 - 2025
7.6.9.3. Market estimates and forecast, by disease, 2014 - 2025
Chapter 8. Company Profiles
8.1. Abbott
8.1.1. Business overview
8.1.2. Financial data
8.1.3. Product landscape
8.1.4. Strategic outlook
8.1.5. SWOT analysis
8.2. Astellas Pharma, Inc.
8.2.1. Business overview
8.2.2. Financial data
8.2.3. Product landscape
8.2.4. Strategic outlook
8.2.5. SWOT analysis
8.3. AstraZeneca
8.3.1. Business overview
8.3.2. Financial data
8.3.3. Product landscape
8.3.4. Strategic outlook
8.3.5. SWOT analysis
8.4. Bristol-Myers Squibb
8.4.1. Business overview
8.4.2. Financial data
8.4.3. Product landscape
8.4.4. Strategic outlook
8.4.5. SWOT analysis
8.5. CSL Limited
8.5.1. Business overview
8.5.2. Financial data
8.5.3. Product landscape
8.5.4. Strategic outlook
8.5.5. SWOT analysis
8.6. Emergent BioSolutions, Inc.
8.6.1. Business overview
8.6.2. Financial data
8.6.3. Product landscape
8.6.4. Strategic outlook
8.6.5. SWOT analysis
8.7. GlaxoSmithKline
8.7.1. Business overview
8.7.2. Financial data
8.7.3. Product landscape
8.7.4. Strategic outlook
8.7.5. SWOT analysis
8.8. Johnson & Johnson
8.8.1. Business overview
8.8.2. Financial data
8.8.3. Product landscape
8.8.4. Strategic outlook
8.8.5. SWOT analysis
8.9. Merck & Co.
8.9.1. Business overview
8.9.2. Financial data
8.9.3. Product landscape
8.9.4. Strategic outlook
8.9.5. SWOT analysis
8.10. Novavax, Inc.
8.10.1. Business overview
8.10.2. Financial data
8.10.3. Product landscape
8.10.4. Strategic outlook
8.10.5. SWOT analysis
8.11. Pfizer
8.11.1. Business overview
8.11.2. Financial data
8.11.3. Product landscape
8.11.4. Strategic outlook
8.11.5. SWOT analysis
8.12. Sanofi Pasteur
8.12.1. Business overview
8.12.2. Financial data
8.12.3. Product landscape
8.12.4. Strategic outlook
8.12.5. SWOT analysis
Data Tables
TABLE 1 Vaccines industry 360 degree synopsis, 2014 - 2025
TABLE 2 Global vaccines market, 2014 - 2018 (USD Million)
TABLE 3 Global vaccines market, 2019 - 2025 (USD Million)
TABLE 4 Global vaccines market, by age group, 2014 - 2018 (USD Million)
TABLE 5 Global vaccines market, by age group, 2019 - 2025 (USD Million)
TABLE 6 Global vaccines market, by technology, 2014 - 2018 (USD Million)
TABLE 7 Global vaccines market, by technology, 2019 - 2025 (USD Million)
TABLE 8 Global vaccines market, by disease, 2014 - 2018 (USD Million)
TABLE 9 Global vaccines market, by disease, 2019 - 2025 (USD Million)
TABLE 10 Global vaccines market, by region, 2014 - 2018 (USD Million)
TABLE 11 Global vaccines market, by region, 2019 - 2025 (USD Million)
TABLE 12 Industry impact forces
TABLE 13 Pediatric vaccine market size, by region, 2014 - 2018 (USD Million)
TABLE 14 Pediatric vaccine market size, by region, 2019 - 2025 (USD Million)
TABLE 15 Adult vaccine market size, by region, 2014 - 2018 (USD Million)
TABLE 16 Adult vaccine market size, by region, 2019 - 2025 (USD Million)
TABLE 17 Conjugate vaccine market size, by region, 2014 - 2018 (USD Million)
TABLE 18 Conjugate vaccine market size, by region, 2019 - 2025 (USD Million)
TABLE 19 Attenuated vaccine market size, by region, 2014 - 2018 (USD Million)
TABLE 20 Attenuated vaccine market size, by region, 2019 - 2025 (USD Million)
TABLE 21 Inactivated & subunit vaccine market size, by region, 2014 - 2018 (USD Million)
TABLE 22 Inactivated & subunit vaccine market size, by region, 2019 - 2025 (USD Million)
TABLE 23 Recombinant vaccine market size, by region, 2014 - 2018 (USD Million)
TABLE 24 Recombinant vaccine market size, by region, 2019 - 2025 (USD Million)
TABLE 25 Toxoid vaccine market size, by region, 2014 - 2018 (USD Million)
TABLE 26 Toxoid vaccine market size, by region, 2019 - 2025 (USD Million)
TABLE 27 Others market size, by region, 2014 - 2018 (USD Million)
TABLE 28 Others market size, by region, 2019 - 2025 (USD Million)
TABLE 29 Cancer market size, by region, 2014 - 2018 (USD Million)
TABLE 30 Cancer market size, by region, 2019 - 2025 (USD Million)
TABLE 31 Hepatitis market size, by region, 2014 - 2018 (USD Million)
TABLE 32 Hepatitis market size, by region, 2019 - 2025 (USD Million)
TABLE 33 Pneumococcal disease market size, by region, 2014 - 2018 (USD Million)
TABLE 34 Pneumococcal disease market size, by region, 2019 - 2025 (USD Million)
TABLE 35 DTP market size, by region, 2014 - 2018 (USD Million)
TABLE 36 DTP market size, by region, 2019 - 2025 (USD Million)
TABLE 37 Dengue market size, by region, 2014 - 2018 (USD Million)
TABLE 38 Dengue market size, by region, 2019 - 2025 (USD Million)
TABLE 39 Influenza market size, by region, 2014 - 2018 (USD Million)
TABLE 40 Influenza market size, by region, 2019 - 2025 (USD Million)
TABLE 41 Human papillomavirus market size, by region, 2014 - 2018 (USD Million)
TABLE 42 Human papillomavirus market size, by region, 2019 - 2025 (USD Million)
TABLE 43 Meningococcal disease market size, by region, 2014 - 2018 (USD Million)
TABLE 44 Meningococcal disease market size, by region, 2019 - 2025 (USD Million)
TABLE 45 Polio market size, by region, 2014 - 2018 (USD Million)
TABLE 46 Polio market size, by region, 2019 - 2025 (USD Million)
TABLE 47 Rotavirus market size, by region, 2014 - 2018 (USD Million)
TABLE 48 Rotavirus market size, by region, 2019 - 2025 (USD Million)
TABLE 49 Others market size, by region, 2014 - 2018 (USD Million)
TABLE 50 Others market size, by region, 2019 - 2025 (USD Million)
TABLE 51 North America vaccines market size, by country, 2014 - 2018 (USD Million)
TABLE 52 North America vaccines market size, by country, 2019 - 2025 (USD Million)
TABLE 53 North America vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 54 North America vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 55 North America vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 56 North America vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 57 North America vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 58 North America vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 59 U.S. vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 60 U.S. vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 61 U.S. vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 62 U.S. vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 63 U.S. vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 64 U.S. vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 65 Canada vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 66 Canada vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 67 Canada vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 68 Canada vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 69 Canada vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 70 Canada vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 71 Europe vaccines market size, by country, 2014 - 2018 (USD Million)
TABLE 72 Europe vaccines market size, by country, 2019 - 2025 (USD Million)
TABLE 73 Europe vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 74 Europe vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 75 Europe vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 76 Europe vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 77 Europe vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 78 Europe vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 79 Germany vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 80 Germany vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 81 Germany vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 82 Germany vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 83 Germany vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 84 Germany vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 85 UK vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 86 UK vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 87 UK vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 88 UK vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 89 UK vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 90 UK vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 91 Italy vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 92 Italy vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 93 Italy vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 94 Italy vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 95 Italy vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 96 Italy vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 97 France vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 98 France vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 99 France vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 100 France vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 101 France vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 102 France vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 103 Spain vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 104 Spain vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 105 Spain vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 106 Spain vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 107 Spain vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 108 Spain vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 109 Russia vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 110 Russia vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 111 Russia vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 112 Russia vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 113 Russia vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 114 Russia vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 115 Asia Pacific vaccines market size, by country, 2014 - 2018 (USD Million)
TABLE 116 Asia Pacific vaccines market size, by country, 2019 - 2025 (USD Million)
TABLE 117 Asia Pacific vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 118 Asia Pacific vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 119 Asia Pacific vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 120 Asia Pacific vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 121 Asia Pacific vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 122 Asia Pacific vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 123 China vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 124 China vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 125 China vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 126 China vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 127 China vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 128 China vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 129 India vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 130 India vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 131 India vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 132 India vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 133 India vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 134 India vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 135 Japan vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 136 Japan vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 137 Japan vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 138 Japan vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 139 Japan vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 140 Japan vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 141 South Korea vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 142 South Korea vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 143 South Korea vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 144 South Korea vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 145 South Korea vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 146 South Korea vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 147 Australia vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 148 Australia vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 149 Australia vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 150 Australia vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 151 Australia vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 152 Australia vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 153 Latin America vaccines market size, by country, 2014 - 2018 (USD Million)
TABLE 154 Latin America vaccines market size, by country, 2019 - 2025 (USD Million)
TABLE 155 Latin America vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 156 Latin America vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 157 Latin America vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 158 Latin America vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 159 Latin America vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 160 Latin America vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 161 Brazil vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 162 Brazil vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 163 Brazil vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 164 Brazil vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 165 Brazil vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 166 Brazil vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 167 Mexico vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 168 Mexico vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 169 Mexico vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 170 Mexico vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 171 Mexico vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 172 Mexico vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 173 Argentina vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 174 Argentina vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 175 Argentina vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 176 Argentina vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 177 Argentina vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 178 Argentina vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 179 MEA vaccines market size, by country, 2014 - 2018 (USD Million)
TABLE 180 MEA vaccines market size, by country, 2019 - 2025 (USD Million)
TABLE 181 MEA vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 182 MEA vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 183 MEA vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 184 MEA vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 185 MEA vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 186 MEA vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 187 South Africa vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 188 South Africa vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 189 South Africa vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 190 South Africa vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 191 South Africa vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 192 South Africa vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 193 Saudi Arabia vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 194 Saudi Arabia vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 195 Saudi Arabia vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 196 Saudi Arabia vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 197 Saudi Arabia vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 198 Saudi Arabia vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 199 UAE vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 200 UAE vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 201 UAE vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 202 UAE vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 203 UAE vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 204 UAE vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 205 Qatar vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 206 Qatar vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 207 Qatar vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 208 Qatar vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 209 Qatar vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 210 Qatar vaccines market size, by disease, 2019 - 2025 (USD Million)
TABLE 211 Egypt vaccines market size, by age group, 2014 - 2018 (USD Million)
TABLE 212 Egypt vaccines market size, by age group, 2019 - 2025 (USD Million)
TABLE 213 Egypt vaccines market size, by technology, 2014 - 2018 (USD Million)
TABLE 214 Egypt vaccines market size, by technology, 2019 - 2025 (USD Million)
TABLE 215 Egypt vaccines market size, by disease, 2014 - 2018 (USD Million)
TABLE 216 Egypt vaccines market size, by disease, 2019 - 2025 (USD Million)
Charts & Figures
FIG. 1 Industry segmentation
FIG. 2 Global vaccines market, 2014- 2025 (USD Million)
FIG. 3 Growth potential analysis, age group
FIG. 4 Growth potential analysis, by technology
FIG. 5 Growth potential analysis, by diseases
FIG. 6 Porter's analysis
FIG. 7 Company share analysis, 2017
FIG. 8 Strategy dashboard
FIG. 9 PESTEL analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report